Cargando…

Saliva diagnostic utility in patients with type 2 diabetes: Future standard method

BACKGROUND: The purpose of the present study was to assess saliva reliability in diagnosis and monitoring type 2 diabetes instead of blood. METHODS: Blood and unstimulated whole saliva were collected from 300 type 2 diabetic subjects and 300 healthy controls in fasting. Then, the salivary flow rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Mrag, Marwa, Kassab, Asma, Omezzine, Asma, Belkacem, Chebil Raoua, Ben, Fredj Ismail Fatma, Douki, Nabiha, Laouani, Kechrid Chedia, Bouslema, Ali, Ben, Amor Faten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Medical Biochemists of Serbia, Belgrade 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526023/
https://www.ncbi.nlm.nih.gov/pubmed/33033445
http://dx.doi.org/10.2478/jomb-2019-0019
_version_ 1783588794604191744
author Mrag, Marwa
Kassab, Asma
Omezzine, Asma
Belkacem, Chebil Raoua
Ben, Fredj Ismail Fatma
Douki, Nabiha
Laouani, Kechrid Chedia
Bouslema, Ali
Ben, Amor Faten
author_facet Mrag, Marwa
Kassab, Asma
Omezzine, Asma
Belkacem, Chebil Raoua
Ben, Fredj Ismail Fatma
Douki, Nabiha
Laouani, Kechrid Chedia
Bouslema, Ali
Ben, Amor Faten
author_sort Mrag, Marwa
collection PubMed
description BACKGROUND: The purpose of the present study was to assess saliva reliability in diagnosis and monitoring type 2 diabetes instead of blood. METHODS: Blood and unstimulated whole saliva were collected from 300 type 2 diabetic subjects and 300 healthy controls in fasting. Then, the salivary flow rate was calculated. All parameters including glucose, urea, amylase, total protein, albumin, C-reactive protein (CRP), immunoglobulin A (IgA), potassium, calcium and chloride were assessed in the supernatant, using an autoanalyzer. Oral exam was conducted by a single examiner on full mouth excluding third molars. Statistical analysis was performed by the SPSS 20.0 version. RESULTS: Saliva screening showed that glucose, urea, amylase, total protein, potassium, calcium and chloride were significantly higher in patients compared to controls (p < 0.05). Whereas, the IgA level and salivary flow rate were significantly reduced in patients (p < 0.05). No significant difference was found in albumin and CRP levels (p > 0.05). There was a significant positive correlation between salivary and plasma glucose levels (r = 0.887, and r = 0.900, p < 0.001), as well as, salivary and blood urea (r = 0.586, and r = 0.688, p < 0.001) in patients and controls, respectively. CONCLUSIONS: From this study, saliva could be suggested as a useful diagnostic tool for type 2 diabetes.
format Online
Article
Text
id pubmed-7526023
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Society of Medical Biochemists of Serbia, Belgrade
record_format MEDLINE/PubMed
spelling pubmed-75260232020-10-07 Saliva diagnostic utility in patients with type 2 diabetes: Future standard method Mrag, Marwa Kassab, Asma Omezzine, Asma Belkacem, Chebil Raoua Ben, Fredj Ismail Fatma Douki, Nabiha Laouani, Kechrid Chedia Bouslema, Ali Ben, Amor Faten J Med Biochem Original Paper BACKGROUND: The purpose of the present study was to assess saliva reliability in diagnosis and monitoring type 2 diabetes instead of blood. METHODS: Blood and unstimulated whole saliva were collected from 300 type 2 diabetic subjects and 300 healthy controls in fasting. Then, the salivary flow rate was calculated. All parameters including glucose, urea, amylase, total protein, albumin, C-reactive protein (CRP), immunoglobulin A (IgA), potassium, calcium and chloride were assessed in the supernatant, using an autoanalyzer. Oral exam was conducted by a single examiner on full mouth excluding third molars. Statistical analysis was performed by the SPSS 20.0 version. RESULTS: Saliva screening showed that glucose, urea, amylase, total protein, potassium, calcium and chloride were significantly higher in patients compared to controls (p < 0.05). Whereas, the IgA level and salivary flow rate were significantly reduced in patients (p < 0.05). No significant difference was found in albumin and CRP levels (p > 0.05). There was a significant positive correlation between salivary and plasma glucose levels (r = 0.887, and r = 0.900, p < 0.001), as well as, salivary and blood urea (r = 0.586, and r = 0.688, p < 0.001) in patients and controls, respectively. CONCLUSIONS: From this study, saliva could be suggested as a useful diagnostic tool for type 2 diabetes. Society of Medical Biochemists of Serbia, Belgrade 2020-01-23 2020-01-23 /pmc/articles/PMC7526023/ /pubmed/33033445 http://dx.doi.org/10.2478/jomb-2019-0019 Text en 2020 Marwa Mrag, Asma Kassab, Asma Omezzine, Chebil Raoua Belkacem, Fredj Ismail Fatma Ben, Nabiha Douki, Kechrid Chedia Laouani, Ali Bouslema, Amor Faten Ben, published by CEON/CEES https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License.
spellingShingle Original Paper
Mrag, Marwa
Kassab, Asma
Omezzine, Asma
Belkacem, Chebil Raoua
Ben, Fredj Ismail Fatma
Douki, Nabiha
Laouani, Kechrid Chedia
Bouslema, Ali
Ben, Amor Faten
Saliva diagnostic utility in patients with type 2 diabetes: Future standard method
title Saliva diagnostic utility in patients with type 2 diabetes: Future standard method
title_full Saliva diagnostic utility in patients with type 2 diabetes: Future standard method
title_fullStr Saliva diagnostic utility in patients with type 2 diabetes: Future standard method
title_full_unstemmed Saliva diagnostic utility in patients with type 2 diabetes: Future standard method
title_short Saliva diagnostic utility in patients with type 2 diabetes: Future standard method
title_sort saliva diagnostic utility in patients with type 2 diabetes: future standard method
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526023/
https://www.ncbi.nlm.nih.gov/pubmed/33033445
http://dx.doi.org/10.2478/jomb-2019-0019
work_keys_str_mv AT mragmarwa salivadiagnosticutilityinpatientswithtype2diabetesfuturestandardmethod
AT kassabasma salivadiagnosticutilityinpatientswithtype2diabetesfuturestandardmethod
AT omezzineasma salivadiagnosticutilityinpatientswithtype2diabetesfuturestandardmethod
AT belkacemchebilraoua salivadiagnosticutilityinpatientswithtype2diabetesfuturestandardmethod
AT benfredjismailfatma salivadiagnosticutilityinpatientswithtype2diabetesfuturestandardmethod
AT doukinabiha salivadiagnosticutilityinpatientswithtype2diabetesfuturestandardmethod
AT laouanikechridchedia salivadiagnosticutilityinpatientswithtype2diabetesfuturestandardmethod
AT bouslemaali salivadiagnosticutilityinpatientswithtype2diabetesfuturestandardmethod
AT benamorfaten salivadiagnosticutilityinpatientswithtype2diabetesfuturestandardmethod